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Strategies for the prevention of asthma remain
elusive [Centers for Disease Control and
Prevention (CDC) 2002; Hartert and Peebles
2000]. In the United States, asthma morbidity
is highest among minorities and persons of
low socioeconomic status (SES) (Grant et al.
2000; Miller 2000). African-American and
Hispanic children in the United States have
emergency department (ED) and hospitaliza-
tion rates for asthma that are two to four
times higher than that observed in Caucasian
children, and African-American asthma mor-
tality rates can be four times higher (CDC
2002; Grant et al. 2000).
Lead poisoning is a serious environmental
health hazard for U.S. children of minority
status and low SES (CDC 2001). The effects
of lead poisoning include delayed cognitive
development, permanent learning disabilities,
and behavior problems (Lanphear et al. 1998,
2002; Needleman 1998). According to
national surveys, African-American children
were found to have blood lead levels (BLL)
four times higher than those of Caucasians
after controlling for income and urban sta-
tus, and were seven times more likely than
Caucasians to require medical evaluation for
lead poisoning (CDC 2001). Although fed-
eral guidelines recommend intervention at
BLL ≥ 10 µg/dL, adverse outcomes have been
demonstrated at lower levels (Bernard and
McGeehin 2003).
The epidemiology of pediatric asthma and
that of lead poisoning are strikingly similar
(Hartert and Peebles 2000; Lanphear et al.
1998). Both are prevalent among minority chil-
dren, and elements in the physical environment
increase risk of disease (Hartert and Peebles
2000; Lanphear et al. 1998; Rosenstreich et al.
1997). Low SES and residing in an urban set-
ting are associated with increased risk for both
conditions (Bernard and McGeehin 2003;
Miller 2000).
Published analyses suggest that lead expo-
sure may result in alterations to immune sys-
tem components known to be associated with
asthma (Lutz et al. 1999; Sun et al. 2003).
Lead has been associated with the increased
production of total immunoglobulin E (IgE),
which is also observed in atopic and nonatopic
individuals with asthma (Beeh et al. 2000;
Romanet-Manent et al. 2002).
The immunotoxic or immunomodulatory
effects of lead have been demonstrated recently
in animal models, and include impaired host
resistance to infections and an enhancement of
alloantigenic-specific T-cell proliferation by
altering antigen processing and presentation
(Gupta et al. 2002; McCabe et al. 2001). Both
Lutz et al. (1999) and Sun et al. (2003) reported
an association between lead and increased IgE in
studies of young children.
We hypothesize that differential risk of
lead poisoning among urban minority children
may contribute to increased risk of asthma in
this population. The overall goal of this analy-
sis was to use encounter and claims data to
examine relationships between BLL and devel-
opment of asthma, by race.
Materials and Methods
Design. The methods of this study were
approved by the Henry Ford Health System
(HFHS) institutional review board. The base
study population was enrollees of a large, non-
profit managed care organization (MCO) in
southeastern Michigan served by physicians in
a staff model medical group. The MCO has a
stable population of > 250,000 with a mean
enrollment of 9.3 years. The MCO enrollment
database and the associated laboratory database
(all lead screens are sent to a single central
laboratory) were linked to identify children
born on or between 1 January 1994 and
31 December 1997, enrolled in the MCO at
time of birth, and with laboratory results for a
lead screen performed between 1 January 1995
and 31 December 1998 (baseline BLL)
[National Institute for Occupational Health
and Safety (NIOSH) 1994]. When results
existed for more than one lead screen for an
individual child, the highest BLL recorded
within the study ascertainment period was
used as the baseline BLL. Usually this was the
ﬁrst BLL documented. The resulting data set
was linked to the patient encounter database to
obtain all ambulatory and inpatient visits, as
well as demographic information, including
child’s date of birth, race, and residential
address. The pharmacy claims database pro-
vided information on drug claims for asthma
medications [Health Employers Data Infor-
mation System (HEDIS) 1999].
MCO enrollment and disenrollment dates
were used to calculate the person-years that each
child contributed to the cohort. Geographic
information system (GIS; Mapping Solutions,
Address correspondence to C.L.M. Joseph, Henry
Ford Health System, Department of Biostatistics and
Research Epidemiology, 1 Ford Pl., Suite 3E, Detroit,
MI 48202 USA. Telephone: (313) 874-6366. Fax:
(313) 874-6730. E-mail: cjoseph1@hfhs.org
We acknowledge the valuable contributions of
R. Rasmusson, K. Wells, and J. Zajechowski in the
preparation of the manuscript.
This research was funded by the National Heart,
Lung, and Blood Institute (R03 HL67462).
The authors declare they have no competing
ﬁnancial interests.
Received 27 July 2004; accepted 3 March 2005.
Blood Lead Level and Risk of Asthma
Christine L.M. Joseph,1 Suzanne Havstad,1 Dennis R. Ownby,2 Edward L. Peterson,1 Mary Maliarik,1
Michael J. McCabe Jr.,3 Charles Barone,1 and Christine Cole Johnson1
1Department of Biostatistics and Research Epidemiology, Henry Ford Health System, Detroit, Michigan, USA; 2Allergy–Immunology
Section, Medical College of Georgia, Augusta, Georgia, USA; 3Department of Environmental Medicine, University of Rochester School
of Medicine, Rochester, New York, USA
Asthma and lead poisoning are prevalent among urban children in the United States. Lead exposure
may be associated with excessive production of immunoglobulin E, possibly increasing asthma risk
and contributing to racial disparities. The objective of this study was to examine racial differences
in the association of blood lead level (BLL) to risk of developing asthma. We established and fol-
lowed a cohort prospectively to determine asthma onset, using patient encounters and drug claims
obtained from hospital databases. Participants were managed care enrollees with BLL measured and
documented at 1–3 years of age. We used multiple variable analysis techniques to determine the
relationship of BLL to period prevalent and incident asthma. Of the 4,634 children screened for
lead from 1995 through 1998, 69.5% were African American, 50.5% were male, and mean age was
1.2 years. Among African Americans, BLL ≥ 5 and BLL ≥ 10 µg/dL were not associated with
asthma. The association of BLL ≥ 5 µg/dL with asthma among Caucasians was slightly elevated,
but not signiﬁcant [adjusted hazard ratio (adjHR) = 1.4; 95% conﬁdence interval (CI), 0.7–2.9; p =
0.40]. Despite the small number of Caucasians with high BLL, the adjHR increased to 2.7 (95%
CI, 0.9–8.1; p = 0.09) when more stringent criteria for asthma were used. When compared with
Caucasians with BLL < 5 µg/dL, African Americans were at a signiﬁcantly increased risk of asthma
regardless of BLL (adjHR = 1.4–3.0). We conclude that an effect of BLL on risk of asthma for
African Americans was not observed. These results demonstrate the need for further exploration of
the complex interrelationships between race, asthma phenotype, genetic susceptibilities,
and socioenvironmental exposures, including lead. Key words: asthma, atopy, environment,
immunoglobulin E, incidence, lead poisoning, racial disparity. Environ Health Perspect
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analysis technology capable of linking geo-
graphic with demographic information, was
used in conjunction with patient address and
census data (U.S. Census Bureau 2000). Each
study participant was assigned the average
income per person in the block group of resi-
dence (a subdivision of a census tract represent-
ing a city block) (Croner et al. 1996).
The method for obtaining birth weight
for children in this cohort was approved by
the State of Michigan Division for Vital
Records and Health Statistics (Lansing, MI)
in addition to the HFHS institutional review
board. Identifiers for members of the study
cohort were matched, at the State of Michigan
Division for Vital Records and Health Statistics
(Lansing, MI), to live birth records. Birth
record identiﬁer ﬁelds were not supplied to the
researchers. Matches outside of the state were
censored. The resulting match rate was 97.8%.
Blood samples were obtained by veni-
puncture, collected in EDTA tubes, and
shipped at room temperature to the HFHS
chemistry laboratory. Lead was measured in
the blood using graphite furnace atomic
absorption spectrophotometry, with detection
limits of 1 µg/dL.
Asthma deﬁnition. We determined asthma
status using enrollee encounter and pharmacy
claims databases from HFHS. Two deﬁnitions
of asthma were used. For deﬁnition 1, a child
was considered to have asthma if the child had
four or more asthma-medication–dispensing
events in 12 months or met one or more of the
following criteria within a 12-month period:
one or more ED visits for asthma, one or more
hospitalizations for asthma, or four or more
outpatient visits for asthma with at least two
asthma-medication–dispensing events. For
definition 2, a child was considered to have
asthma if the child had four or more asthma-
medication–dispensing events in 12 months,
and had one or more ED visits for asthma, one
or more hospitalizations for asthma, or four or
more outpatient visits for asthma with at least
two asthma-medication–dispensing events
(HEDIS 1999). These deﬁnitions are used by
HEDIS to define an MCO population of
patients with persistent asthma.
Statistical analysis. We determined period
prevalence of asthma at baseline by taking
the number of deﬁnition 1 or 2 asthma cases
occurring from birth to 12 months after the
index BLL and dividing it by the total number
of children in the cohort at that time. Children
who did not meet the criteria for asthma during
this period were considered “asthma free” and
used in the incident asthma analysis. Children
meeting criteria for asthma during the postbase-
line follow-up period were considered incident
asthma cases. We calculated incidence density
(ID) by taking the number of asthma cases that
developed during the postbaseline follow-up
period and dividing by the total number of
person-years contributed to the cohort during
this period (Pearce et al. 1998). Data were cen-
sored when a patient disenrolled from the
MCO. Chi-square tests were used to compare
sex, race, and baseline income proportions for
children included in the study with those of
children excluded from the study because of
lack of a recorded BLL. We used a Wilcoxon
rank-sum test to compare the distributions of
BLL by race.
We assessed racial differences in the num-
ber of asthma cases using logistic regression for
period prevalent cases and Cox proportional
hazards for incident cases. The cutoffs used
for BLL in these analyses were ≥ 5 µg/dL and
≥ 10 µg/dL. The association of period preva-
lent asthma to BLL was evaluated by comput-
ing odds ratios (ORs) and corresponding 95%
confidence intervals (CIs). We evaluated the
association of BLL to asthma incident cases
by computing the hazard ratio (HR) along
with the corresponding 95% CIs. We used a
Cox proportional hazard to determine the
independent association of BLL to asthma
incident cases (Diggle et al. 1994). These mod-
els adjusted for average annual income per
person, birth weight, and sex. Separate models
were run for ≥ 5 µg/dL and ≥ 10 µg/dL for
each race using < 5 µg/dL as the comparison
group. In addition, separate models were
run for African Americans and Caucasians at
each cut point, using Caucasians with BLL
< 5 µg/dL as the comparison group, allowing
direct comparison of the risk estimates.
Results
Table 1 shows the characteristics of the study
population. Of the 31,526 children born
between 1 January 1994 and 31 December
1997 and enrolled in the MCO, 4,634 had
lead screening results in the laboratory database
and were recorded as being African American
or Caucasian. Children with lead screening
results differed demographically from children
without lead screens in terms of sex (fewer
males in study sample; p = 0.02), race (more
African Americans in study sample; p < 0.001),
and median annual income (lower income for
children in study sample; p < 0.001). The latter
was observed regardless of race.
The percentages of children with BLL ≥
5 µg/dL and ≥ 10 µg/dL were 39.0 and
8.6%, respectively. The overall mean BLL for
the entire sample was 4.7 µg/dL (SD = 4.0,
median = 4.0 µg/dL). African Americans had
a higher mean BLL when compared with
Caucasians, 5.5 µg/dL (SD = 4.3, median =
4.0 µg/dL) versus 3.2 µg/dL (SD = 2.5,
median = 3.0 µg/dL), respectively, p < 0.01.
The period prevalence of asthma at base-
line was 7.5% for definition 1 and 2.4%
for deﬁnition 2 (Table 1). The period preva-
lence of definition 1 asthma among African
Americans at baseline was 8.9% compared
with 4.1% for Caucasians, p < 0.01 (Table 2).
The period prevalence of deﬁnition 2 asthma
among African Americans was 2.6% com-
pared with 1.8% for Caucasians, p = 0.12.
The ID for the entire cohort was 2.4 and
0.9 per 100 person-years for deﬁnition 1 and
definition 2 asthma, respectively. The ID of
deﬁnition 1 asthma among African Americans
was 3.0/100 person-years compared with
1.2/100 person-years for Caucasians, p < 0.01.
The ID of deﬁnition 2 asthma among African
Americans was 1.1/100 person-years versus
0.4/100 person-years for Caucasians, p = 0.01.
Table 2 shows a univariate analysis of the
association of study variables to asthma preva-
lent and incident cases. African-American race,
male sex, birth weight ≤ 2,500 g, and annual
income ≤ $10,027 (the median income per
person for the study population) were signiﬁ-
cantly related to prevalent asthma (all p-values
< 0.01). When compared with the reference
group of BLL < 5 µg/dL, the OR (95% CI) for
prevalent asthma was 1.2 (0.9–1.5), p = 0.14,
for BLL ≥ 5 µg/dL, and 1.0 (0.7–1.6), p =
0.87, for BLL ≥ 10 µg/dL. African-American
race, male sex, and birth weight ≤ 2,500 g
were significantly associated with incident
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Table 1. Characteristics of the study population.
Characteristic No. Value
Age (years) at baseline BLL [mean ± SD (range)] 4,634 1.2 ± 0.5 (0.4–3.0)
Annual household income per person [US$ mean ± SD (range)] 4,450 10,579 ± 5,615 (1,819–47,077)
Sex
Male 2,340 50.5
Female 2,294 49.5
Race
African American 3,220 69.5
Caucasian 1,414 30.5
BLL (µg/dL)
≥ 5 1,808 39.0
≥ 10 401 8.6
Period prevalence
of asthmaa
Deﬁnition 1 346 7.5
Deﬁnition 2 109 2.4
Values are percentage except where otherwise noted.
aAsthma cases occurring from birth up to 12 months after the index BLL.
Blood lead level and risk of asthmaasthma (all p-values < 0.01). The HR for BLL
≥ 5 µg/dL and incident asthma was 1.2
(1.0–1.6), p = 0.09 and for BLL ≥ 10 µg/dL
was 1.0 (0.6–1.6), p = 0.97.
Results of Cox proportional hazards analy-
sis are shown in Table 3. All analyses were
adjusted for annual income ≤ $10,027, birth
weight, and sex. Among Caucasians, the
adjusted HR (adjHR) for deﬁnition 1 asthma
was only slightly elevated for BLL ≥ 5 µg/dL
and was not statistically signiﬁcant (adjHR =
1.4; 95% CI, 0.7–2.9; p = 0.40). Again, there
was no association between BLL ≥ 10 µg/dL
and asthma. The risk estimate for deﬁnition 2
asthma was elevated for Caucasians with BLL ≥
5 µg/dL but did not reach statistical signiﬁcance
(adjHR = 2.7; 95% CI, 0.9–8.1; p = 0.09).
Among African Americans, BLL was not
associated with developing definition 1 or 2
asthma.
We also conducted the Cox proportional
hazards analysis for the association of BLL to
incident asthma, using Caucasians with BLL
< 5 µg/dL as reference (Table 4). Results were
similar to that shown in Table 3, in that the
adjHR for developing deﬁnition 1 asthma for
Caucasians with BLL ≥ 5 µg/dL was elevated,
but not signiﬁcant, and BLL was not associ-
ated to incident asthma among Caucasians
with BLL ≥ 10 µg/dL when compared with
the reference group. AdjHRs (95% CIs) for
African Americans with BLL < 5 µg/dL and
BLL ≥ 5 µg/dL were 1.6 (1.4–2.0) and 1.4
(1.2–1.6), respectively, when compared with
the reference group (both p < 0.01). At BLL
≥ 10 µg/dL, the adjHR (95% CI) for risk
of asthma for African Americans was 2.1
(1.2–3.6), p = 0.01, for deﬁnition 1 and 3.0
(1.2–7.1), p = 0.01, for deﬁnition 2.
Discussion
Lead poisoning and asthma jeopardize the
health and quality of life of urban minority
children in the United States (Bernard and
McGeehin 2003; Lanphear et al. 2002). We
sought to evaluate the contribution of BLL to
the increased risk of asthma among African
Americans. BLL was less a predictor of asthma
than was race and did not affect the relation-
ship of race to prevalent or incident asthma.
Because lead poisoning and asthma share risk
factors that are heavily inﬂuenced by SES, it is
difﬁcult to obtain an unbiased estimate of the
true relationship (Bernard and McGeehin
2003; Lanphear et al. 1996; Needleman 1998).
Previous studies have shown an association
between BLL and serum IgE, and because
serum IgE is observed in both atopic and
nonatopic asthma, it was of interest to deter-
mine whether a relationship between BLL and
development of asthma could be demonstrated
using secondary data sources. To our knowl-
edge, there are no studies that have looked at
BLL and the incidence of asthma by race.
We observed an elevated risk of asthma
among children exposed to lead, although
these associations were not always statistically
signiﬁcant and were observed only for certain
subgroups. Three interesting findings can
be garnered from this study. First, a trend
toward elevated risk estimates for asthma was
observed for BLL at a cut point lower than
what is currently considered toxic (Bernard
and McGeehin 2003; Burns et al. 1999;
Needleman and Landrigan 2004). Second, in
addition to a trend toward increased risk at
lead levels ≥ 5 µg/dL, the elevated risk was
observed consistently only for Caucasians.
Although the risk of developing asthma was
signiﬁcantly increased for African Americans
Joseph et al.
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Table 2. Association of study variables to asthma period prevalence and incidence.a
Prevalent asthma Incident asthmab
Asthma No asthma OR No. of Person- HR
Variable [n (%)] [n (%)] (95% CI) p-Value cases years (95% CI) p-Value
African American 288 (8.9) 2,932 (91.1) 2.3 (1.7–3.1) < 0.01 235 7,734 2.5 (1.8–3.4) < 0.01
Caucasian 58 (4.1) 1,356 (95.9) 47 4,053
Male 213 (9.1) 2,127 (90.9) 1.6 (1.3–2.0) < 0.01 166 5,876 1.4 (1.1–1.8) < 0.01
Female 133 (5.8) 2,161 (94.2) 116 5,912
BW ≤ 2,500 g 63 (13.5) 405 (86.5) 2.1 (1.6–2.8) < 0.01 38 1,054 1.5 (1.1–2.1) < 0.02
BW > 2,500 g 277 (6.9) 3,754 (93.1) 240 10,427
Income ≤ $10,132c 206 (9.1) 2,054 (90.9) 1.6 (1.3–2.0) < 0.01 138 5,218 1.1 (0.9–1.4) 0.35
Income > $10,132 128 (5.8) 2,062 (94.2) 139 6,205
BLL < 5 µg/dL 198 (7.0) 2,628 (93.0) 1.0 166 7,639 1.0
BLL ≥ 5 µg/dL 148 (8.2) 1,660 (91.8) 1.2 (0.9–1.5) 0.14 116 4,148 1.2 (1.0–1.6) 0.09
BLL ≥ 10 µg/dL 29 (7.2) 372 (92.8) 1.0 (0.7–1.6) 0.87 20 875 1.0 (0.6–1.6) 0.97
BW, birth weight.
aDeﬁnition 1 asthma; all persons with deﬁnition 2 asthma also fulﬁlled criteria for deﬁnition 1. bAsthma cases per 100 person-
years of enrollment ascertained during follow-up period (12 months postbaseline).cMedian income for the study sample.
Table 3. Results of Cox proportional hazards multivariable analysis of the association of BLL to incident
asthma by race.a
Deﬁnition/race BLL (µg/dL) No. With asthma [n (%)] AdjHR (95% CI) p-Value
Deﬁnition 1 asthma
Caucasian < 5 1,065 37 (3.5) 1.0
≥ 5 218 10 (4.6) 1.4 (0.7–2.9) 0.40
≥ 10 27 1 (3.7) 1.1 (0.2–8.4) 0.91
African American < 5 1,472 129 (8.8) 1.0
≥ 5 1,351 106 (7.9) 1.0 (0.8–1.3) 0.94
≥ 10 322 19 (5.9) 0.9 (0.5–1.4) 0.58
Deﬁnition 2 asthma
Caucasian < 5 1,085 12 (1.1) 1.0
≥ 5 221 5 (2.2) 2.7 (0.9–8.1) 0.09
≥ 10 28 0 —
African American < 5 1,580 51 (3.2) 1.0
≥ 5 1,444 43 (3.0) 1.1 (0.8–1.7) 0.53
≥ 10 340 9 (2.7) 1.3 (0.6–2.6) 0.54
—, not calculated.
aModels adjusted for average annual income per person, birth weight, and sex. Separate models were created for
≥ 5 µg/dL and ≥ 10 µg/dL, both using < 5 µg/dL as the comparison group.
Table 4. Results of Cox proportional hazards multivariable analysis of the association of BLL to incident
asthma using one race-exposure reference group.a
Deﬁnition/race BLL (µg/dL) No. With asthma [n (%)] AdjHR (95% CI) p-Value
Deﬁnition 1 asthma
Caucasian < 5 1,065 37 (2.9) 1.0
≥ 5 218 10 (4.6) 1.4 (0.7–2.9) 0.33
≥ 10 27 1 (3.7) 1.1 (0.1–7.7) 0.96
African American < 5 1,472 129 (8.8) 1.6 (1.4–2.0) < 0.01
≥ 5 1,351 106 (7.9) 1.4 (1.2–1.6) < 0.01
≥ 10 322 19 (5.9) 2.1 (1.2–3.6) 0.01
Deﬁnition 2 asthma
Caucasian < 5 1,085 12 (1.1) 1.0
≥ 5 221 5 (2.2) 2.3 (0.8–6.7) 0.12
≥ 10 28 0 —
African American < 5 1,580 51 (3.2) 1.8 (1.3–2.4) < 0.01
≥ 5 1,444 43 (3.0) 1.5 (1.2–1.8) < 0.01
≥ 10 340 9 (2.7) 3.0 (1.2–7.1) 0.01
—, not calculated.
aModels adjusted for average annual income per person, birth weight, and sex. Data represent ﬁve separate models, all
using Caucasian with BLL < 5 µg/dL as the comparison group.when compared with Caucasians with BLL
< 5 µg/dL, the risk was not dependent on BLL;
that is, African Americans with BLL < 5 µg/dL
were also at increased risk of asthma. Third,
although our results are inconclusive regarding
a dose–response relationship for BLL and
asthma, among African Americans BLL
≥ 10 µg/dL held a higher risk of asthma than
did BLL ≥ 5 µg/dL. Among Caucasians, the
adjHR for BLL and incident asthma increased
as the asthma definition became more strin-
gent. However, because BLL is an inadequate
dosimeter of lead exposure, a dose–response
relationship between BLL and asthma may
not be observed in our data, if such a relation-
ship exists.
The trend toward an elevated risk of
asthma observed among Caucasians with BLL
≥ 5 µg/dL could be a residual effect of factors
unadjusted for in our analysis. If so, these risk
estimates may indicate the presence of environ-
mental exposures related to both BLL and
asthma. Because the baseline BLL in this study
could have been measured as late as 3 years of
age, exposure to factors related to asthma may
have already occurred. If this is true, BLL
≥ 5 µg/dL recorded during early infancy could
be an indicator that risk factors for asthma are
also present in the environment. There is
growing evidence that exposures and events
occurring during the ﬁrst year of life are impor-
tant determinants of the development of atopy
and asthma (Holt 1998; Johnson et al. 1996,
2002; Joseph et al. 2002; Ownby et al. 2002).
The racial differences observed are of inter-
est. It was clear that African Americans were at a
signiﬁcantly higher risk of developing asthma
when compared with Caucasians, regardless of
BLL. The effect of BLL on the immune system
of African-American children may be masked by
more inﬂuential factors working to increase risk
(Holt 1998; Joseph et al. 2000, 2002). Again,
BLL may signal the presence of indoor environ-
mental risk factors for asthma that play a greater
role in development of the disease for African
Americans. Racial differences in factors related
to asthma, both environmental and otherwise,
have been previously reported. Differential sen-
sitization for indoor and outdoor allergens by
race has been documented in at least two studies
(Celedon et al. 2004; Joseph et al. 2000).
Another possible explanation is the racial dif-
ference observed in IgE (Joseph et al. 2000;
Oettgen and Geha 1999). In a previous study,
we found that total IgE was higher for African
Americans when compared with Caucasians
among children with and without asthma, and
that total IgE in African Americans was not
related to bronchial hyperresponsiveness, despite
the observed association in Caucasians (Joseph
et al. 2000). Perhaps Caucasians are more sen-
sitive to the effect of low levels of lead, whereas
the BLLs studied were not high enough to
induce an effect in African Americans.
Differences in lead sources may explain
variations observed. A study conducted by
Lanphear et al. (1998) reported differences in
housing conditions and exposures to lead-
contaminated house dust that contributed to
observed racial differences in BLL. Although
lead-contaminated soil was a risk factor for
both racial groups, African-American children
were more likely to be exposed to indoor
environmental sources of lead (e.g., lead-
contaminated house dust, painted surfaces,
and floors in poor condition), whereas out-
door sources were more likely for Caucasian
children (Lanphear et al. 1998).
Genetic variation may explain racial dif-
ferences in susceptibility to lead poisoning.
The C282Y mutation in the HFE gene caus-
ing hemochromatosis, and the gene coding
for δ-aminolevulinic acid dehydratase, an
enzyme of heme synthesis, are both associated
with increased lead absorption. The vitamin D
receptor gene can lead to increased production
of calcium-binding proteins, also resulting in
increased lead absorption. These genetic varia-
tions have not been shown to explain racial
differences in lead toxicity (Lanphear et al.
1996; Onalaja and Claudio 2000; Wright
et al. 2004).
The role of environmental lead in the
development of atopic asthma is hypothesized
to be mediated through IgE. The division of
asthma into two clinical variants based on
atopy continues to be controversial, but high
total IgE is actually characteristic of both
groups (Beeh et al. 2000; Romanet-Manent
et al. 2002). It has been proposed that lead
acts to increase production of IgE through
direct or indirect stimulation of B-cells or
through the binding and subsequent altera-
tion of allergens that stimulate the allergenic
immune response (Annesi-Maesano et al.
2003; Lutz et al. 1999). Several studies report
an association between lead and IgE, but we
found only one study exploring the relation-
ship between lead and an asthma diagnosis:
The study by Bener et. al. (2001), conducted
in United Arab Emirates, found that indus-
trial workers had significantly higher BLL
(77.5 µg/dL, SD = 42.8) compared with non-
industrial workers (19.8 µg/dL, SD = 12.3)
and that the former also had a higher preva-
lence of asthma and respiratory symptoms.
Lead levels below those recognized as
unsafe have been shown to inhibit production
of interferon-γ, a TH1 immune response, and
enhance TH2 responses [e.g., interleukin
(IL)-4, IL-5, IL-10, IL-13, and IgE)] (Annesi-
Maesano et al. 2003; Miller et al. 1998).
Results of a laboratory study by Snyder et al.
(2000) found evidence for maternal transfer of
lead both transplacentally and lactationally in
pregnant BALB/c mice and their offspring. The
authors found that mouse neonates exposed
to lead transplacentally and/or lactationally
had significantly higher plasma IgE levels.
Higher IgE levels among individuals exposed to
lead have been corroborated in several human
studies. Lutz et al. (1999) conducted a study of
BLL and IgE in a predominantly Caucasian
study population of 279 young children partici-
pating in the WIC (Women, Infants, Children)
Nutritional Support Program and selected lead
prevention programs active in Greene County,
Missouri during the study period. In this
study, BLL was significantly and positively
associated with serum IgE levels. No relation-
ship between cytokines measured in the blood
and BLL was observed. Boscolo and col-
leagues (1999, 2000) examined the role of
trace metals, including lead, in expression of
lymphocyte subpopulations and cytokine
serum levels in asymptomatic, atopic urban
men and women. Atopy was deﬁned as “evi-
dent clinical history of allergic symptoms.” In
men, blood lead (mean BLL = 11 µg/dL) had
an immunomodulatory effect on CD4+ and
B-lymphocytes that appeared to enhance the
production of TH2-like cytokines and IgE
(Boscolo et al. 1999). Women 19–49 years of
age had slightly higher BLL among those
that were atopic (median BLL = 64 µg/dL
for atopic vs. 55 µg/dL for nonatopic), but
although serum IgE levels were higher in
atopic women, TH2-like cytokines and blood
lymphocyte subpopulations did not differ
significantly by atopic status (Boscolo et al.
2000). The authors suggested that differences
in lead metabolism or hormonal secretion by
sex may explain the dissimilar results. Sun
et al. (2003) conducted a study in a small
number of preschool children (n = 73) in the
People’s Republic of China. Overall, serum
concentrations of IgE were higher in the high
BLL group (≥ 10 µg/dL), but the association
was of borderline significance (p = 0.069).
When stratifying by sex, Sun et al. found that
serum IgE levels were significantly higher
only for females in the high BLL group (p =
0.027).
Limitations to this analysis include restrict-
ing this study to children enrolled in the MCO
with results of lead screens in the laboratory
database. This study population was more
likely to be African American and had lower
annual incomes per person than did those
without a recorded BLL in the HFHS labora-
tory database. It is reasonable that African
Americans and persons of low SES would
be favored for lead screening in the MCO.
According to the CDC and other sources,
African-American and poor children in the
United States are at a higher risk of lead
poisoning when compared with Caucasian
and with affluent children (Bernard and
McGeehin 2003). The median BLL in this
study (4.0 µg/dL) was higher than that
reported for U.S. children 1–5 years of age
(2.2 µg/dL) and for those with family incomes
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less than poverty level (2.8 µg/dL), according
to national data for 1999–2000, indicating
that children at risk are overrepresented in
this cohort [U.S. Environmental Protection
Agency (EPA) 2004].
Also excluded from this study would be
children who received a lead screen using a
finger or heel stick. In the laboratory data-
base, lead levels are the result of venipuncture,
which is considered more reliable than other
methods (e.g., ﬁnger or heel stick). This was
also a strength in that it permitted assessment
of BLLs < 10 µg/dL.
Variables for analysis were limited to
those collected in our hospital database.
Consequently, there was no information on
potential sources of lead. Parasitic infection is
more prevalent among low SES groups, as is
lead toxicity, potentially confounding a rela-
tionship between BLL and asthma, especially
if the lead source is outdoors (Hagel et al.
2004). Moreover, we did not have infor-
mation on other environmental exposures
known to be associated with both asthma and
BLL (e.g., environmental tobacco smoke,
diesel exhaust) or other medical risk factors
potentially associated with risk of asthma
(e.g., family history of asthma or allergy,
breast feeding, diet) (Johnson et al. 1996;
Mannino et al. 2003). Using a definition of
asthma based on encounters and prescription
claims did not allow an investigation of dif-
fering asthma phenotypes, such as allergic
asthma or transient wheeze (Martinez 2002;
Romanet-Manent et al. 2002). Use of these
databases, however, did allow a noninvasive
exploration of the relationship of BLL and
asthma in a population with both African-
American and Caucasian representation.
Using the MCO patient population may have
reduced biases due to disparities in health care
access, and having addresses allowed for
geocoding that resulted in the ability to adjust
for surrogate measures of SES (annual income
per person).
We observed a trend toward an elevated
risk of developing asthma in Caucasian chil-
dren with evidence of BLL of ≥ 5 µg/dL before
the age of 3 years. Assessment of the effect of
BLL on IgE may provide a better understand-
ing of the etiology and prevention of atopy
and asthma. African Americans were at an
increased risk of asthma when compared with
Caucasians, but if there were any effects related
to BLL, they were not observed. The racial dif-
ferences observed in this study illustrate the
need for further exploration of the role of race
in the interrelationships between genetic sus-
ceptibility, socioenvironmental exposures, and
risk of asthma.
REFERENCES
Annesi-Maesano I, Pollitt R, King G, Bousquet J, Hellier G,
Sahuqulllo J, et al. 2003. In utero exposure to lead and cord
blood total IgG. Is there a connection? Allergy 58:589–594.
Beeh KM, Ksoll M, Buhl R. 2000. Elevation of total serum
immunoglobulin E is associated with asthma in non-allergic
individuals. Eur Respir J 16:609–614.
Bener A, Almehdi AM, Alwash R, Al-Neamy FRM. 2001. A pilot
survey of blood lead levels in various types of workers in
the United Arab Emirates. Environ Int 27:311–314.
Bernard SM, McGeehin MA. 2003. Prevalence of blood lead
levels > or = 5 micro g/dL among U.S. children 1 to 5 years
of age and socioeconomic and demographic factors
associated with blood of lead levels 5 to 10 micro g/dL,
Third National Health and Nutrition Examination Survey,
1988–1994. Pediatrics 112(6 pt 1):1308–1313.
Boscolo P, Di Gioacchino M, Sabbioni E, Benvenuti F, Conti P,
Reale M, et al. 1999. Expression of lymphocyte subpopula-
tions, cytokine serum levels, and blood and urinary trace
elements in asymptomatic atopic men exposed to an urban
environment. Int Arch Occup Environ Health 72(1):26–32.
Boscolo P, Di Gioaccino M, Sabbioni E, Di Giacomo F, Reale M,
Volpe AR, et al. 2000. Lymphocyte subpopulations, cytokines
and trace elements in asymptomatic atopic women exposed
to an urban environment. Life Sci 67:1119–1126.
Burns JM, Baghurst PA, Sawyer MG, McMichael AJ, Tong SL.
1999. Lifetime low-level exposure to environmental lead and
children’s emotional and behavioral development at ages
11–13 years. The Port Pirie Cohort Study. Am J Epidemoil
149(8):740–749.
CDC (Centers for Disease Control and Prevention). 2001. Blood
lead levels in young children—United States and selected
states, 1996–1999. JAMA 285(3):286–287.
CDC (Centers for Disease Control and Prevention). 2002.
Surveillance for asthma—United States, 1980–1999.
MMWR Surveil Summ 51(SS01):1–13.
Celedon JC, Sredl D, Weiss ST, Pisarski M, Wakefield D,
Cloutier M. 2004. Ethnicity and skin test reactivity to aeroal-
lergens among asthmatic children in Connecticut. Chest
125:85–92.
Croner CM, Sperling J, Broome FR. 1996. Geographic Infor-
mation Systems (GIS): new perspectives in understanding
human health and environmental relationships. Stat Med
15:1961–1977.
Diggle PJ, Liang K, Zeger SL. 1994. Analysis of Longitudinal
Data. New York:Oxford Science Publications.
Grant EN, Lyttle CS, Weiss KB. 2000. The relation of socio-
economic factors and racial/ethnic differences in U.S.
asthma mortality. Am J Public Health 90(12):1923–1925.
Gupta P, Husain MM, Shankar R, Maheshwari RK. 2002. Lead
exposure enhances virus multiplication and pathogenesis
in mice. Vet Hum Toxicol 44:205–210.
Hagel I, Di Prisco MC, Goldblatt J, Le Souef PN. 2004. The role
of parasites in genetic susceptibility to allergy. Clin Rev
Allergy Immunol 26:75–82.
Hartert TV, Peebles RS Jr. 2000. Epidemiology of asthma: the
year in review. Curr Opin Pulm Med 6:4–9.
HEDIS (Health Employers Data Information) 2000. 1999.
Appropriate Medications for People with Asthma. Vol 2.
Technical Specifications. Washington, DC:National
Committee for Quality Assurance.
Holt PG. 1998. Programming for responsiveness to environmental
antigens that trigger allergic respiratory disease in adult-
hood is initiated during the perinatal period. Environ Health
Perspect 106:795–800.
Johnson CC, Peterson EL, Ownby DR. 1996. Factors associated
with asthma in a birth cohort of children followed to six
years of age [Abstract]. J Allergy Clin Immunol 97:376.
Joseph CLM, Ownby DR, Peterson EL, Johnson CC. 2000. Racial
differences in physiologic parameters related to asthma
among middle-class children. Chest 117(5):1336–1344.
Joseph CLM, Ownby DR, Peterson EL, Johnson CC. 2002. Does
low birth weight help to explain the increased prevalence
of asthma among African-Americans? Ann Allergy Asthma
Immunol 88:507–512.
Lanphear BP, Byrd RS, Auinger P, Schaffer SJ. 1998. Community
characteristics associated with elevated blood lead levels
in children. Pediatrics 101(2):264–271.
Lanphear BP, Hornung R, Ho M, Howard CR, Eberle S, Knauf K.
2002. Environmental lead exposure during early childhood.
J Pediatr 140:40–47.
Lanphear BP, Weitzman M, Eberly S. 1996. Racial differences in
urban children’s environmental exposures to lead. Am J
Public Health 86:1460–1463.
Lutz PM, Wilson TJ, Ireland J, Jones AL, Gorman JS, Gale NL,
et al. 1999. Elevated immunoglobulin E (IgE) levels in chil-
dren with exposure to environmental lead. Toxicology
134(1):63–78.
Mannino DM, Albalak R, Grosse S, Repace J. 2003. Second-hand
smoke exposure and blood lead levels in U.S. children.
Epidemiology 14(6):719–727.
Martinez FD. 2002. What have we learned from the Tucson
Children’s Respiratory Study? Paediatr Respir Rev
3(3):193–197.
McCabe MJ Jr, Singh KP, Reiners JJ Jr. 2001. Low level lead
exposure in vitro stimulates the proliferation and expan-
sion of alloantigen-reactive CD4(high) T cells. Toxicol Appl
Pharmacol 177(3):219–231.
Miller JE. 2000. The effects of race/ethnicity and income on
early childhood asthma prevalence and health care use.
Am J Public Health 90:428–430.
Miller TE, Golemboski KA, Ha RS, Bunn T, Sanders FS, Dietert
RR. 1998. Developmental exposure to lead causes per-
sistent immunotoxicity in Fischer 344 rats. Toxicol Sci
42(2):129–135.
Needleman HL. 1998. Childhood lead poisoning: the promise
and abandonment of primary prevention. Am J Public
Health 88:1871–1877.
Needleman HL, Landrigan PJ. 2004. What level of lead in blood
is toxic for a child? [Comment]. Am J Public Health 94(1):8.
NIOSH. 1994. Manual of Analytical Methods (NMAM). 4th ed.
Publication 94-113. Cincinnati, OH:National Institute for
Occupational Safety and Health.
Oettgen HC, Geha RS. 1999. IgE in asthma and atopy: cellular
and molecular connections. J Clin Invest 104(7):829–835.
Onalaja AO, Claudio L. 2000. Genetic susceptibility to lead poi-
soning. Environ Health Perspect 108(suppl 1):23–28.
Ownby DR, Johnson CC, Peterson EL. 2002. Exposure to dogs
and cats in the ﬁrst year of life and risk of allergic sensiti-
zation at 6 to 7 years of age. JAMA 288:963–972.
Pearce N, Beasley R, Burgess C, Crane J. 1998. Asthma
Epidemiology. Principals and Methods. New York:Oxford
University Press.
Romanet-Manent S, Charpin D, Magnan A, Lanteaume A,
Vervloet D. 2002. Allergic vs. nonallergic asthma: what
makes the difference? Allergy 57(7):607–613.
Rosenstreich DL, Eggleston P, Kattan M, Baker D, Slavin RG,
Gergen P, et al. 1997. The role of cockroach allergy and
exposure to cockroach allergen in causing morbidity
among inner-city children with asthma. N Engl J Med
336(19):1356–1363.
Snyder JE, Filipov NM, Parsons PJ, Lawrence DA. 2000. The
efﬁciency of maternal transfer of lead and its inﬂuence on
plasma IgE and splenic cellularity of mice. Toxicol Sci
57:87–94.
Sun Li, Hu J, Zhao Z, Lon L, Cheng H. 2003. Inﬂuence of expo-
sure to environmental lead on serum immunoglobulin in
preschool children. Environ Res 92:124–128.
U.S. Census Bureau. 2000. 2000 Decennial Census of
Population and Housing Summary File 3. Washington,
DC:U.S. Census Bureau.
U.S. EPA. 2004. American’s children and the environment (ACE).
Median concentrations of lead in blood of children ages
1–5, by race/ethnicity and family income, 1999–2000.
Centers for Disease Control and Prevention, National
Center for Health Statistics, National Health and Nutrition
Examination Survey. Washington, DC:U.S. Environmental
Protection Agency. Available: http://www.epa.gov/enviro
health/children/body_burdens/b2.htm [accessed 30 August
2004].
Wright RO, Silverman EK, Schwartz J, Tsaih S, Senter J,
Sparrow D, et al. 2004. Association between hemochro-
matosis genotype and lead exposure among elderly men:
the Normative Aging Study. Environ Health Perspect
112:746–750.